• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Dermatology’s Growth Never Slows Down

Dermatology TimesDermatology Times, March 2024 (Vol. 45. No. 03)
Volume 45
Issue 03

Our March 2024 publication features stories that reflect the sense of growth and newness in the specialty.

BillionPhotos.com/Adobe Stock
BillionPhotos.com/Adobe Stock

Spring is just around the corner, and the sense of growth and newness is felt in dermatology with upcoming conferences, pipeline updates, and continued breaking news. As always, Dermatology Times will be here to provide the latest in dermatology updates for your practice and patients.

The 2024 American Academy of Dermatology (AAD) Annual Meeting has been the talk of March as dermatology clinicians from across the country take clinical pearls back to their practices from the numerous sessions and late-breaking data on treatment options and innovations for a wealth of skin conditions and populations. If you are an AAD presenter and would like an opportunity to discuss your research further, email DTEditor@mmhgroup.com. Or if you did not present at AAD but want to share your favorite pearls or tips you learned, email us for an opportunity to be featured.

March has many important awareness initiatives to spotlight, including Women’s History Month, International Women’s Day, and International Transgender Day of Visibility. In this month’s issue, we asked Glynis Ablon, MD, FAAD; Tina S. Alster, MD, FAAD; Renata Block, MMS, PA-C; Dawn Eichenfield, MD; Mona Gohara, MD; and Amy Spizuoco, DO, FAOCD, FAAD, what it means to them to be a leading woman in dermatology. Additionally, Ilya Petrou, MD, dives into a recent study on hidradenitis suppurativa (HS) in transgender and gender-diverse patients to better understand the effects of hormone therapy on HS exacerbation and how to best support patients.

We are also excited to publish a feature by Nicole A. Negbenebor, MD, on the lack of access to Mohs micrographic surgery treatment for incarcerated patients in the US. Negbenebor explores the numerous barriers to dermatologic care in prisons, including inaccessibility to health programs, required prison guard escort to appointments, and the lack of clarity regarding follow-up appointments.

Whether you are taking a break from conference travel or are catching up on the latest late-breaking data, subscribe to Dermatology Times e-newsletters to stay informed. Don’t forget to also follow us on social media and email us with ideas and feedback at DTEditor@mmhgroup.com.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.